Global X Genomics & Biotechnology ETF
GNOM$54.92 -0.18 (-0.33%)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| July 7, 2026 | $0.06 | 2026-06-29 | 2026-06-29 |
| January 7, 2026 | $0.59 | 2025-12-30 | 2025-12-30 |
| July 7, 2025 | $0.01 | 2025-06-27 | 2025-06-27 |
| January 7, 2022 | $0.01 | 2021-12-30 | 2021-12-31 |
| January 8, 2021 | $0.03 | 2020-12-30 | 2020-12-31 |
Dividends Summary
- Consistent Payer: Global X Genomics & Biotechnology ETF has rewarded shareholders with 5 dividend payments over the past 5 years.
- Total Returned Value: Investors who held GNOM shares during this period received a total of $0.70 per share in dividend income.
- Latest Payout: The most recent dividend of $0.06/share was paid 11 days ago, on July 7, 2026.
- Dividend Growth: Since 2021, the dividend payout has grown by 78.6%, from $0.03 to $0.06.
Company News
Top ETFs Tracking CRISPR Gene Editing
These exchange-traded funds track companies in this biotech space.
Will 2023 be the Year of Cathie Wood ETFs?
Cathie Wood, famous for the success of Ark Investment's winning products, had faced a miserable fate in 2022. Will her ETFs see success in 2023?
Pharma & Biotech ETFs at One-Month High: Here's Why
Pharma and biotech ETFs are in great shape and are trading at a one-month high level.
Is ARK's Stellar Run Over? 5 ETF Themes to Follow Cathie Wood
Though Cathie Wood's Ark Investment's star products underperformed in 2021 and may continue to lag the broader market in 2022, Wood's fans may follow these ETF strategies to capitalize on her vision.
